Replies to post #5944 on BioSante Pharmaceuticals, Inc. (BPAX)

[Rustler]

I'm for whatever will work. If BPAX can resurrect the damage done to Libigel and actually find retail distribution channels to move the product, they green light the deal and let's go. I personally believe that BPAX has its work cut out for it on that front, however.